Asia Pacific Infectious Respiratory Disease Diagnostics Market Size & Outlook

The infectious respiratory disease diagnostics market in Asia Pacific is expected to reach a projected revenue of US$ 16.7 million by 2030. A compound annual growth rate of 5.8% is expected of Asia Pacific infectious respiratory disease diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$11.9
Forecast, 2030 (US$M)
$16.7
CAGR, 2025 - 2030
5.8%
Report Coverage
Asia Pacific

Asia Pacific infectious respiratory disease diagnostics market, 2018-2030 (US$M)

Asia

Asia Pacific infectious respiratory disease diagnostics market highlights

  • The Asia Pacific infectious respiratory disease diagnostics market generated a revenue of USD 11.9 million in 2024.
  • The market is expected to grow at a CAGR of 5.8% from 2025 to 2030.
  • In terms of segment, instruments was the largest revenue generating product in 2024.
  • Instruments is the most lucrative product segment registering the fastest growth during the forecast period.

Asia Pacific data book summary

Market revenue in 2024USD 11.9 million
Market revenue in 2030USD 16.7 million
Growth rate5.8% (CAGR from 2024 to 2030)
Largest segmentInstruments
Fastest growing segmentInstruments
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments
Key market players worldwideAbbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 21.8% of the global infectious respiratory disease diagnostics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 16.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Respiratory Disease Diagnostics Market Scope

Infectious respiratory disease diagnostics market segmentation & scope
Imaging tests
Other Instruments
Consumables
Services
Sample Type
Saliva
Nasopharyngeal Swabs (NPS)
Anterior Nasal Region
Blood
Others
Technology Type
Immunoassay
Molecular Diagnostics
Microbiology
Other technologies
Application
COVID-19
Influenza
RSV (Respiratory Syncytial Virus)
Tuberculosis
Streptococcus Testing
Other Respiratory Disease Testing
End Use
Hospitals
Diagnostic Laboratories
Physician Offices
Other end-users

Infectious Respiratory Disease Diagnostics Market Companies

Name Profile # Employees HQ Website

Asia Pacific infectious respiratory disease diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.


Instruments was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the Asia Pacific infectious respiratory disease diagnostics market based on instruments covering the revenue growth of each sub-segment from 2018 to 2030.


Increase in pro-health initiatives, adoption of better technologies, and rise in consumer awareness are driving market growth in this region. In addition, rising prevalence of infectious diseases, increasing demand for diagnostic products, and growing population base significantly contribute to market growth.

Asia Pacific markets such as China, Australia, Korea, and Taiwan already have a healthcare reimbursement system that provides an inclusive coverage for diagnostic tests. Increasing initiatives for scientific research, and positive economic growth coupled with high unmet needs are some primary growth drivers of this market.

Moreover, improving healthcare regulatory scenario in the high growth countries is expected to attract international players to invest and capitalize on the available opportunities. Positive changes, such as healthcare benefits by government, increased awareness amongst the population, and an urge to avail high-end medical treatment are also expected to drive regional market growth.

Reasons to subscribe to Asia Pacific infectious respiratory disease diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific infectious respiratory disease diagnostics market databook

  • Our clientele includes a mix of infectious respiratory disease diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific infectious respiratory disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific infectious respiratory disease diagnostics market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more